Kojo S. J. Elenitoba-Johnson, MD, is the inaugural Peter C. Nowell, MD Professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine, University of Pennsylvania. He is also the Founding Director of Penn Medicine’s Center for Personalized Diagnostics, as well as Chief of the Division of Precision and Computational Diagnostics.
Dr. Elenitoba-Johnson is an international leader in the field of Hematopathology and Molecular Pathology, as well as mass spectrometry-driven proteomics. Dr. Elenitoba-Johnson earned his MD from the College of Medicine at the University of Lagos, in Nigeria. He underwent residency training in Anatomic and Clinical Pathology at Brown University School of Medicine. He completed a fellowship in Hematopathology at the National Cancer Institute, National Institutes of Health. He is certified by the American Board of Pathology in Combined Anatomic and Clinical Pathology, with sub-specialty certification in Hematology and Molecular Genetic Pathology.
Dr. Elenitoba-Johnson’s research is focused on the pathogenesis of human malignant lymphomas and cancer biomarker discovery by genomic and proteomic profiling. Dr. Elenitoba-Johnson has been recognized for his work with numerous awards, including the American Society of Investigative Pathology Scholarship in 1993; the Outstanding Graduating Resident Award from Brown University in 1995; the Society for Hematopathology Pathologist in Training Award in 1998; the Outstanding Teaching Award in Anatomic Pathology from the University of Utah (1999 and 2003); and the Ramzi Cotran Young Investigator Award from the United States and Canadian Academy of Pathology in 2006. He is an elected member of the American Society for Clinical Investigation (2011), and is the recipient of the Outstanding Investigator Award given by the American Society for Investigative Pathology (2012). His work has been supported by extramural awards including grants from the National Institutes of Health (NIH).
Dr. Elenitoba-Johnson is a member for the Board of Scientific Counselors of the National Cancer Institute of the NIH. He is an Associate Editor for the Journal of Hematopathology and a member of numerous professional societies, including the American Society of Hematology, American Society for Investigative Pathology, United States and Canadian Academy of Pathologists, and the Association of Molecular Pathologists (AMP). He served as the Chair of the Hematopathology Division of AMP from 2008-2009. He has authored or co-authored more than 130 peer-reviewed research publications and has contributed more than 40 chapters to professional textbooks in Pathology.